Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development

Open Access

Peer-reviewed

Research Article

Benjamin M. Ford,

Affiliation Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America
⨯
Lirit N. Franks,

Affiliation Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America
⨯
Anna Radominska-Pandya,

Affiliation Department of Biochemistry and Molecular Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America
⨯
Paul L. Prather

* E-mail: PratherPaulL@uams.edu

Affiliation Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America
⨯

Reader Comments (0)

Isomers
Is the Subject Area "Isomers" applicable to this article?

Thanks for your feedback.
Adenylyl cyclase
Is the Subject Area "Adenylyl cyclase" applicable to this article?

Thanks for your feedback.
Cannabinoids
Is the Subject Area "Cannabinoids" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.